Ibrutinib/Rituximab versus Placebo/Rituximab: A Randomized, Phase 3 Trial in Waldenstrom's Macroglobulinemia (iNNOVATE)

M Lia Palomba, Meletios A Dimopoulos, Alessandra Tedeschi, Judith Trotman, Ramon Garcia-Sanz, David MacDonald, Veronique Leblond, Beatrice Mahe, Charles Herbaux, Constantine Tam, Jeffrey V Matous, Chaim Shustik, Efstathios Kastritis, Steven P Treon, Jianling Li, Zeena Salman, Thorsten Graef, Christian Buske